Demo

2903 Articles Matching "data"

Novartis executive sold shares before drug data manipulation made public

Aug 19, 2019 , Reuters
An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated....
Read more

As Americans get heavier, obesity-linked cancers may strike earlier

Aug 17, 2019 , Reuters
Increasing numbers of middle-aged Americans appear to be developing cancers that can be associated with obesity, new data suggest....
Read more

U.K. Firm Creates 'Operating System' To Handle Massive Genomic Patient Data Sets

Aug 17, 2019 , Forbes
We’re making work digital on every desktop, we’re empowering digital sensors in the Internet of Things (IoT) on every street corner, we’re building smart digital AI-powered IT systems with machine learning and decision-making abilities to automate our lives… and we’re digitizing ourselves as...
Read more

Global Measles Cases Nearly Tripled Since Last Year, WHO Says

Aug 17, 2019 , RxList
Among media reports of the death of a 44-year-old Israeli flight attendant and mother of three after contracting measles, preliminary data released by the World Health Organization (WHO) on August 12 show that the number of global cases of the disease during the first half of this year has not been this high since 2006, with annual numbers rising steadily since...
Read more

Research Shows Improvement In Curbing Docs’ Post-Surgical Prescribing, But There’s Still A Long Way To Go

Aug 16, 2019 , Kaiser Health News
And the Connecticut Mirror pulls from a database obtained by The Washington Post that offers an up-close look at the rates of opioid-pill dispensing by the state's pharmacies between 2006 and 2012....
Read more
Demo

Cedars-Sinai study on inpatient VR pain management offers glimpse at real-world outcomes

Aug 15, 2019 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
Positive data from the pragmatic study is the clearest evidence yet that in-hospital therapeutic VR could be effective in a live deployment, according to...
Read more

Novartis replaces top scientists at Avexis after drug data manipulated

Aug 15, 2019 , Reuters
Novartis AG said on Wednesday it replaced the two top research and development executives at its Avexis unit after some data was manipulated from early testing of a gene therapy for infants that costs more than $2 million....
Read more

Hospital Deals With Drugmakers To Mine Patients’ Genetic Data Raise Privacy Concerns

Aug 14, 2019 , Kaiser Health News
Drugmakers have been buying access to patients’ genetic code data from hospitals. But those facilities don't always disclose to patients the full ways their data could be used. In other news, Modern Healthcare reports on how policy differences complicate potential business deals between religious and secular...
Read more

Biobanking Is Changing The World

Aug 13, 2019 , Forbes
With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming...
Read more

Senator Grassley seeks info on Novartis's Zolgensma data issues

Aug 13, 2019 , Reuters
U.S. Senate Finance Committee Chairman Chuck Grassley has asked Swiss drugmaker Novartis AG to provide details on data manipulation related to its $2 million gene therapy, Zolgensma, by Aug. 23....
Read more

U.S. budget deficit widens; spending up on health, military

Aug 13, 2019 , Reuters
The U.S. government's deficit widened to $120 billion in July, fueled by increases in spending on health care and the military, according to data released on Monday by the Treasury Department....
Read more
Demo

UK Boosts Funding For Healthcare AI As Experts Warn Over Data Security

Aug 09, 2019 , Forbes
British prime minister Boris Johnson is pledging more cash for AI - but can data be kept...
Read more

Apple, Eli Lilly, Evidation Health joint study suggests device sensors can spot cognitive decline

Aug 09, 2019 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
These data provide a proof of concept that Apple products and other consumer devices can play a role in monitoring or identifying disease...
Read more

Novartis says it knew of Zolgensma data problems before U.S. approval

Aug 08, 2019 , Reuters
Swiss Drugmaker Novartis AG on Wednesday said it knew about discrepancies in data it submitted to regulators as it sought approval of its more than $2 million gene therapy Zolgensma, but delayed notifying authorities until it completed an internal investigation....
Read more

Healthcare video game maker Level Ex explores medical simulations for astronauts

Aug 08, 2019 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
Using data from NASA, the startup will be building tools that show how low gravity affects the human body, and how medical issues can be addressed during...
Read more

FDA Says Approval of World's Priciest Drug Was Based on Manipulated Data

Aug 08, 2019 , MedicineNet
Title: FDA Says Approval of World's Priciest Drug Was Based on Manipulated DataCategory: Health NewsCreated: 8/6/2019 12:00:00 AMLast Editorial Review: 8/7/2019 12:00:00...
Read more

FDA: Pricey Drug Approved on Manipulated Data

Aug 08, 2019 , WebMD
The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS...
Read more

Novartis Concealed Manipulated Data From FDA While Seeking Approval For $2.1M Gene Therapy Drug

Aug 08, 2019 , Kaiser Health News
Officials say the issue doesn't put patients at risk, but the drugmaker could face penalties for withholding the information. The news has also unsettled an industry where many are racing to be the first to come out with these expensive gene therapies....
Read more

U.S. FDA says some data testing Novartis' $2 million gene therapy was manipulated

Aug 07, 2019 , Reuters
The U.S. Food and Drug Administration said on Tuesday that some data from early testing of Novartis' more than $2 million gene therapy Zolgensma was manipulated, but the agency believes the treatment should remain on the market....
Read more

FDA threatens criminal penalties against Novartis over faulty data used in gene therapy application

Aug 07, 2019 , CNBC Health
Shares of the Swiss drugmaker tumbled 3.6% in early afternoon trading...
Read more